Atherosclerosis
Volume 206, Issue 2 , Pages 335-339 , October 2009

Association of inflammatory markers with angiographic severity and extent of coronary artery disease

Received 26 November 2008 ,Revised 26 January 2009 ,Accepted 26 January 2009.

References 

  1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–e146
  2. Thim T, Hagensen MK, Bentzon JF, Falk E. From vulnerable plaque to atherothrombosis. J Intern Med. 2008;263(5):506–516
  3. Hingorani AD, Shah T, Casas JP, Humphries SE, Talmud PJ. C-reactive protein and coronary heart disease: predictive test or therapeutic target?. Clin Chem. 2008;
  4. Maier W, Altwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation. 2005;111(11):1355–1361
  5. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207
  6. Espinola-Klein C, Rupprecht HJ, Bickel C, et al. Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis. 2007;195(2):e126–134
  7. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12(1):56–62
  8. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343(13):915–922
  9. Fishbein MC, Siegel RJ. How big are coronary atherosclerotic plaques that rupture?. Circulation. 1996;94(10):2662–2666
  10. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138(5 Pt 2):S419–S420
  11. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998;18(5):842–851
  12. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 1992;6(8):2591–2599
  13. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension. 2004;44(1):6–11
  14. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108(16):1930–1932
  15. Yasojima K, Schwab C, McGeer EG, McGeer PL. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol. 2001;158(3):1039–1051
  16. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol. 1996;156(12):4815–4820
  17. Bisoendial RJ, Kastelein JJ, Stroes ES. C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis. 2007;195(2):e10–e18
  18. Tomai F, Crea F, Gaspardone A, et al. Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation. 2001;104(13):1471–1476
  19. Cleland SJ, Sattar N, Petrie JR, et al. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond). 2000;98(5):531–535
  20. Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102(9):1000–1006
  21. Nabata A, Kuroki M, Ueba H, et al. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis. 2008;196(1):129–135
  22. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103(9):1194–1197
  23. Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107(13):1783–1790
  24. Hoffmeister A, Rothenbacher D, Bazner U, et al. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol. 2001;87(3):262–266
  25. Inoue T, Komoda H, Nonaka M, et al. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol. 2008;124(3):319–325
  26. Azar RR, Aoun G, Fram DB, et al. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests. Am J Cardiol. 2000;86(2):205–207
  27. Abdelmouttaleb I, Danchin N, Ilardo C, et al. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J. 1999;137(2):346–351
  28. Arroyo-Espligucro R, Avanzas P, Quiles J, et al., Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 2008; in press.
  29. Sukhija R, Fahdi I, Garza L, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol. 2007;99(7):879–884
  30. Zebrack JS, Anderson JL. The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Curr Cardiol Rep. 2002;4(4):278–288
  31. Yip HK, Wu CJ, Hang CL, et al. Levels and values of inflammatory markers in patients with angina pectoris. Int Heart J. 2005;46(4):571–581
  32. Videm V, Wiseth R, Gunnes S, Madsen HO, Garred P. Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol. 2007;118(1):81–87
  33. Mori T, Sasaki J, Kawaguchi H, et al. Serumglycoproteins and severity of coronary atherosclerosis. Am Heart J. 1995;129(2):234–238
  34. Erren M, Reinecke H, Junker R, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol. 1999;19(10):2355–2363
  35. Memon L, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, et al. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease. Tohoku J Exp Med. 2006;209(3):l97–206
  36. Gotsman I, Stabholz A, Planer D, et al. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?. Isr Med Assoc J. 2008;10(7):494–498
  37. Lombardo A, Biasucci LM, Lanza GA, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation. 2004;109(25):3158–3163
  38. Taniguchi H, Momiyama Y, Ohmori R, et al. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis. 2005;178(1):173–177
  39. Katritsis D, Korovesis S, Giazitzoglou E, et al. C-Reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem. 2001;47(5):882–886
  40. Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J. 2000;21(12):1000–1008
  41. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349(9050):462–466
  42. Toutouzas K, Drakopoulou M, Markou V, et al. Increased coronary sinus blood temperature: correlation with systemic inflammation. Eur J Clin Invest. 2006;36(4):218–223
  43. Sano T, Tanaka A, Namba M, et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation. 2003;108(3):282–285
  44. Hong MK, Park SW, Lee CW, et al. Prospective comparison of coronary artery remodeling between acute coronary syndrome and stable angina in single-vessel disease: correlation between C-reactive protein and extent of arterial remodeling. Clin Cardiol. 2003;26(4):169–172
  45. Hong YJ, Mintz GS, Kim SW, et al. Impact of plaque rupture and elevated C-reactive protein on clinical outcome in patients with acute myocardial infarction: an intravascular ultrasound study. J Invasive Cardiol. 2008;20(9):428–435
  46. Sawada T, Shite J, Shinke T, et al. Relationship between high sensitive C-reactive protein and coronary plaque component in patients with acute coronary syndrome: virtual histology study. J Cardiol. 2006;48(3):141–150
  47. Andrie RP, Bauriedel G, Braun P, et al. Increased expression of C-reactive protein and tissue factor in acute coronary syndrome lesions Correlation with serum C-reactive protein, angioscopic findings, and modification by statins. Atherosclerosis. 2008;
  48. Raffel OC, Tearney GJ, Gauthier DD, et al. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol. 2007;27(8):1820–1827
  49. Tanaka A, Imanishi T, Kitabata H, et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol. 2008;102(8):975–979

PII: S0021-9150(09)00085-9

doi: 10.1016/j.atherosclerosis.2009.01.041

Atherosclerosis
Volume 206, Issue 2 , Pages 335-339 , October 2009

Article Tools